These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 10204718)
1. Differential effects of neurotoxic destruction of descending noradrenergic pathways on acute and persistent nociceptive processing. Martin WJ; Gupta NK; Loo CM; Rohde DS; Basbaum AI Pain; 1999 Mar; 80(1-2):57-65. PubMed ID: 10204718 [TBL] [Abstract][Full Text] [Related]
2. Long-term effects of decreased noradrenergic central nervous system innervation on pain behavior and opioid antinociception. Jasmin L; Boudah A; Ohara PT J Comp Neurol; 2003 May; 460(1):38-55. PubMed ID: 12687695 [TBL] [Abstract][Full Text] [Related]
3. Central noradrenergic lesioning using anti-DBH-saporin: anatomical findings. Wrenn CC; Picklo MJ; Lappi DA; Robertson D; Wiley RG Brain Res; 1996 Nov; 740(1-2):175-84. PubMed ID: 8973812 [TBL] [Abstract][Full Text] [Related]
4. Activation of coeruleospinal noradrenergic inhibitory controls during withdrawal from morphine in the rat. Rohde DS; Basbaum AI J Neurosci; 1998 Jun; 18(11):4393-402. PubMed ID: 9592116 [TBL] [Abstract][Full Text] [Related]
5. Brainstem noradrenergic control of nociception is abnormal in the spontaneously hypertensive rat. Taylor BK; Roderick RE; Basbaum AI Neurosci Lett; 2000 Sep; 291(3):139-42. PubMed ID: 10984626 [TBL] [Abstract][Full Text] [Related]
6. Depletion of endogenous noradrenaline does not prevent spinal cord plasticity following peripheral nerve injury. Hayashida K; Peters CM; Gutierrez S; Eisenach JC J Pain; 2012 Jan; 13(1):49-57. PubMed ID: 22155404 [TBL] [Abstract][Full Text] [Related]
7. Effects of neurotoxic destruction of descending noradrenergic pathways on cannabinoid antinociception in models of acute and tonic nociception. Gutierrez T; Nackley AG; Neely MH; Freeman KG; Edwards GL; Hohmann AG Brain Res; 2003 Oct; 987(2):176-85. PubMed ID: 14499961 [TBL] [Abstract][Full Text] [Related]
9. Demonstration of two separate descending noradrenergic pathways to the rat spinal cord: evidence for an intragriseal trajectory of locus coeruleus axons in the superficial layers of the dorsal horn. Fritschy JM; Grzanna R J Comp Neurol; 1990 Jan; 291(4):553-82. PubMed ID: 2329191 [TBL] [Abstract][Full Text] [Related]
10. Sympathetic reflexes after depletion of bulbospinal catecholaminergic neurons with anti-DbetaH-saporin. Schreihofer AM; Guyenet PG Am J Physiol Regul Integr Comp Physiol; 2000 Aug; 279(2):R729-42. PubMed ID: 10938264 [TBL] [Abstract][Full Text] [Related]
11. Visualizing acute pain-morphine interaction in descending monoamine nuclei with Fos. Bajic D; Commons KG Brain Res; 2010 Jan; 1306():29-38. PubMed ID: 19833107 [TBL] [Abstract][Full Text] [Related]
12. The projections of noradrenergic neurons in the A5 catecholamine cell group to the spinal cord in the rat: anatomical evidence that A5 neurons modulate nociception. Clark FM; Proudfit HK Brain Res; 1993 Jul; 616(1-2):200-10. PubMed ID: 7689410 [TBL] [Abstract][Full Text] [Related]
13. The antinociceptive action of supraspinal opioids results from an increase in descending inhibitory control: correlation of nociceptive behavior and c-fos expression. Gogas KR; Presley RW; Levine JD; Basbaum AI Neuroscience; 1991; 42(3):617-28. PubMed ID: 1659673 [TBL] [Abstract][Full Text] [Related]
14. Noradrenergic lesioning with an anti-dopamine beta-hydroxylase immunotoxin. Picklo MJ; Wiley RG; Lappi DA; Robertson D Brain Res; 1994 Dec; 666(2):195-200. PubMed ID: 7882029 [TBL] [Abstract][Full Text] [Related]
15. Repeated Administration of Amitriptyline in Neuropathic Pain: Modulation of the Noradrenergic Descending Inhibitory System. Hiroki T; Suto T; Saito S; Obata H Anesth Analg; 2017 Oct; 125(4):1281-1288. PubMed ID: 28787345 [TBL] [Abstract][Full Text] [Related]
16. Interactions of intrathecally administered ziconotide, a selective blocker of neuronal N-type voltage-sensitive calcium channels, with morphine on nociception in rats. Wang YX; Gao D; Pettus M; Phillips C; Bowersox SS Pain; 2000 Feb; 84(2-3):271-81. PubMed ID: 10666532 [TBL] [Abstract][Full Text] [Related]
18. Microinjection of morphine in the A7 catecholamine cell group produces opposing effects on nociception that are mediated by alpha1- and alpha2-adrenoceptors. Holden JE; Schwartz EJ; Proudfit HK Neuroscience; 1999; 91(3):979-90. PubMed ID: 10391476 [TBL] [Abstract][Full Text] [Related]
19. Effect of 6-hydroxydopamine-induced lesions to ascending and descending noradrenergic pathways on morphine analgesia. Sawynok J; Reid A Brain Res; 1987 Sep; 419(1-2):156-65. PubMed ID: 3119144 [TBL] [Abstract][Full Text] [Related]
20. Noradrenergic neurons in the locus coeruleus contribute to neuropathic pain. Brightwell JJ; Taylor BK Neuroscience; 2009 Apr; 160(1):174-85. PubMed ID: 19223010 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]